Ming-Tsan Lin Selected Research

Total Parenteral Nutrition

1/2015	Prospective double-blind randomized study on the efficacy and safety of an n-3 fatty acid enriched intravenous fat emulsion in postsurgical gastric and colorectal cancer patients.
3/2008	Effect of perioperative parenteral nutritional support for gastric cancer patients undergoing gastrectomy.
2/2007	Effects of omega-3 fatty acids on leukocyte Th1/Th2 cytokine and integrin expression in rats with gut-derived sepsis.
3/2005	Effects of glutamine supplementation on splenocyte cytokine mRNA expression in rats with septic peritonitis.
3/2004	Glutamine supplementation enhances mucosal immunity in rats with Gut-Derived sepsis.
3/2004	Effects of glutamine supplementation on innate immune response in rats with gut-derived sepsis.
11/2003	Microbiology difference between colonized catheters and catheter-related bloodstream infections.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ming-Tsan Lin Research Topics

Disease

36	Neoplasms (Cancer) 01/2021 - 03/2002
25	Stomach Neoplasms (Stomach Cancer) 01/2019 - 04/2002
20	Sepsis (Septicemia) 01/2022 - 07/2002
10	Inflammation (Inflammations) 01/2022 - 09/2002
9	Neoplasm Metastasis (Metastasis) 01/2018 - 02/2003
7	Obesity 02/2022 - 11/2014
7	Wounds and Injuries (Trauma) 01/2022 - 10/2010
6	Body Weight (Weight, Body) 03/2017 - 07/2002
6	Carcinoma (Carcinomatosis) 01/2008 - 01/2002
5	Weight Loss (Weight Reduction) 08/2021 - 11/2014
5	Infections 01/2017 - 04/2002
5	Carcinogenesis 01/2015 - 07/2004
4	Pain (Aches) 01/2022 - 04/2008
4	Hypoxia (Hypoxemia) 11/2021 - 06/2008
4	Insulin Resistance 01/2020 - 05/2015
4	Breast Neoplasms (Breast Cancer) 07/2019 - 02/2003
3	Colorectal Neoplasms (Colorectal Cancer) 09/2016 - 06/2013
3	Lymphatic Metastasis 07/2015 - 03/2002
3	Flatulence 05/2013 - 09/2008
2	Critical Illness (Critically Ill) 01/2021 - 09/2012
2	Fistula 10/2020 - 06/2008
2	Lung Injury 01/2020 - 01/2019
2	Adenocarcinoma 04/2019 - 06/2007
2	Malnutrition (Nutritional Deficiencies) 04/2019 - 03/2008
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2017 - 04/2016
2	Colonic Neoplasms (Colon Cancer) 12/2016 - 09/2016
2	Appendicitis 05/2013 - 11/2006
2	Cholecystitis 01/2012 - 01/2009
2	Acute Cholecystitis 01/2012 - 01/2009
2	Neuroblastoma 02/2006 - 03/2005
1	Pneumoperitoneum 01/2022
1	Gallbladder Diseases (Gall Bladder Disease) 01/2022
1	Acute Lung Injury 09/2021
1	Morbid Obesity 08/2021

Drug/Important Bio-Agent (IBA)

14	Glutamine (L-Glutamine)FDA Link 11/2021 - 03/2004
12	CytokinesIBA 11/2021 - 01/2002
9	Proteins (Proteins, Gene)FDA Link 04/2020 - 02/2003
8	salicylhydroxamic acid (SHAM)IBA 04/2020 - 03/2004
7	Messenger RNA (mRNA)IBA 11/2021 - 02/2003
6	Glucose (Dextrose)FDA LinkGeneric 02/2022 - 03/2005
5	IntegrinsIBA 12/2012 - 06/2004
4	Interleukin-6 (Interleukin 6)IBA 04/2019 - 07/2004
4	Indicators and Reagents (Reagents)IBA 04/2011 - 04/2002
3	InterleukinsIBA 04/2020 - 01/2019
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2019 - 01/2002
3	CateninsIBA 12/2016 - 01/2015
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2016 - 07/2004
3	RNA (Ribonucleic Acid)IBA 11/2012 - 02/2003
3	Cysteine (L-Cysteine)FDA Link 06/2008 - 11/2007
2	Calcitriol (Calcijex)FDA LinkGeneric 01/2022 - 09/2021
2	Serum AlbuminIBA 01/2021 - 03/2008
2	Lipid PeroxidesIBA 01/2021 - 10/2003
2	Caseins (Casein)FDA Link 04/2020 - 01/2019
2	Arginine (L-Arginine)FDA Link 04/2020 - 01/2020
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 04/2020 - 01/2020
2	Nitric Oxide Synthase (NO Synthase)IBA 04/2020 - 01/2020
2	Insulin (Novolin)FDA Link 01/2020 - 01/2019
2	Connective Tissue Growth FactorIBA 07/2019 - 04/2009
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2019 - 05/2015
2	Therapeutic UsesIBA 01/2018 - 10/2011
2	MicroRNAs (MicroRNA)IBA 01/2017 - 09/2011
2	Plasminogen Activators (Plasminogen Activator)IBA 12/2016 - 06/2008
2	Biomarkers (Surrogate Marker)IBA 07/2015 - 04/2005
2	Vascular Endothelial Growth Factor DIBA 07/2015 - 04/2011
2	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2015 - 02/2007
2	LigandsIBA 05/2014 - 01/2014
2	Formyl Peptide Receptors (Formyl Peptide Receptor)IBA 05/2014 - 12/2012
2	Chemokine ReceptorsIBA 01/2014 - 11/2007
2	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 12/2012 - 11/2012
2	Biological ProductsIBA 09/2009 - 02/2006
2	Interleukin-1beta (Interleukin 1 beta)IBA 05/2006 - 09/2002
2	NF-kappa B (NF-kB)IBA 06/2004 - 02/2003
2	EnzymesIBA 10/2003 - 09/2002
2	Interleukin-10 (Interleukin 10)IBA 05/2003 - 01/2002
1	LeptinIBA 02/2022
1	Carbon DioxideIBA 01/2022
1	Volatile Organic CompoundsIBA 01/2022
1	SmokeIBA 01/2022
1	CalpainIBA 11/2021
1	Leucine (L-Leucine)FDA Link 11/2021
1	Vitamin D FDA LinkGeneric 09/2021

Therapy/Procedure

17	Gastrectomy 02/2022 - 11/2006
17	Ligation 01/2022 - 07/2002
17	Punctures 01/2022 - 07/2002
8	Length of Stay 09/2017 - 09/2008
7	Total Parenteral Nutrition 01/2015 - 11/2003
5	Bariatric Surgery 02/2022 - 06/2013
5	Drug Therapy (Chemotherapy) 01/2021 - 06/2003
4	Laparoscopic Cholecystectomy 01/2022 - 01/2009
4	Minimally Invasive Surgical Procedures 01/2022 - 04/2008
4	Therapeutics 01/2020 - 04/2002
3	Gastric Bypass (Roux-en-Y Gastric Bypass) 11/2014 - 06/2008
3	Operative Time 04/2011 - 04/2008
2	Cholecystectomy 01/2022 - 01/2013
2	Intraperitoneal Injections 11/2021 - 01/2015
2	Laparotomy 01/2020 - 10/2011
2	Lymph Node Excision (Lymph Node Dissection) 01/2017 - 04/2011
2	Neoadjuvant Therapy 04/2009 - 04/2002
2	Catheters 07/2007 - 11/2003
1	Injections 11/2021